We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.88%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$33.9B
AUM Growth
-$12.9B
(-28%)
Cap. Flow
-$11.3B
Cap. Flow
% of AUM
-33.44%
Top 10 Holdings %
Top 10 Hldgs %
7.18%
Holding
4,846
New
656
Increased
881
Reduced
976
Closed
2,305
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 14.66% |
| 3 | Industrials | 10.21% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Financials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alcoa
AA
$11.8B
| $174M | 0.51% |
1,936,105
-579,072
| -23% | -$42.1M |
|
27
Boston Scientific
BSX
$72B
| $174M | 0.51% |
3,925,476
-177,090
| -4% | -$7.67M |
|
28
Novartis
NVS
$292B
| $170M | 0.5% |
1,931,954
+133,629
| +7% | +$11.6M |
|
|
AVGOP
29
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
| $168M | 0.5% |
85,606
+38,000
| +80% | +$70.1M |
|
30
American Airlines Group
AAL
$10.6B
| $164M | 0.48% |
8,959,525
+4,126,874
| +85% | +$70.1M |
|
|
DOCU
31
DocuSign
DOCU
$10.5B
| $159M | 0.47% |
1,482,759
+1,379,434
| +1,335% | +$158M |
|
32
Atlassian
TEAM
$26.3B
| $157M | 0.46% |
534,867
-74,397
| -12% | -$22.2M |
|
33
PepsiCo
PEP
$191B
| $156M | 0.46% |
+930,236
| New | +$156M |
|
34
Ford
F
$57.5B
| $156M | 0.46% |
9,206,843
+1,177,566
| +15% | +$22.4M |
|
35
Antero Resources
AR
$11.2B
| $155M | 0.46% |
5,063,715
+2,683,596
| +113% | +$60.3M |
|
|
P
36
Everpure Inc
P
$26.6B
| $153M | 0.45% |
4,344,561
-582,338
| -12% | -$16.9M |
|
37
Invesco QQQ Trust
QQQ
$469B
| $153M | 0.45% |
420,849
-157,873
| -27% | -$56.1M |
|
38
Gilead Sciences
GILD
$163B
| $151M | 0.45% |
2,541,130
+1,085,059
| +75% | +$69.4M |
|
39
Adobe
ADBE
$99.9B
| $150M | 0.44% |
+329,996
| New | +$159M |
|
40
AbbVie
ABBV
$433B
| $146M | 0.43% |
900,337
-1,025,909
| -53% | -$149M |
|
41
AT&T
T
$162B
| $145M | 0.43% |
+8,123,583
| New | +$150M |
|
42
Regeneron Pharmaceuticals
REGN
$78.2B
| $145M | 0.43% |
207,430
-115,987
| -36% | -$73.4M |
|
43
Carnival Corporation Ltd
CCL
$39.4B
| $145M | 0.43% |
7,152,331
-1,506,540
| -17% | -$30.5M |
|
44
Twilio
TWLO
$29.8B
| $142M | 0.42% |
861,439
+854,533
| +12,374% | +$156M |
|
45
Biogen
BIIB
$29.8B
| $140M | 0.41% |
663,532
+185,871
| +39% | +$40.4M |
|
46
Pinduoduo
PDD
$128B
| $138M | 0.41% |
3,444,578
+2,988,606
| +655% | +$154M |
|
47
Check Point Software Technologies
CHKP
$12.6B
| $138M | 0.41% |
995,828
+194,129
| +24% | +$25.3M |
|
48
EQT Corp
EQT
$33.5B
| $134M | 0.4% |
3,896,544
+3,422,851
| +723% | +$83.5M |
|
49
Target
TGT
$67.8B
| $132M | 0.39% |
+620,016
| New | +$134M |
|
50
Blackrock
BLK
$175B
| $131M | 0.39% |
171,097
+165,378
| +2,892% | +$129M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Investments held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Two Sigma Investments withdrew a net $11.3B in Q1 2022, closing 2,305 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Two Sigma Investments opened a new position in Cisco worth $223M.
- Two Sigma Investments's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- Two Sigma Investments added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- Two Sigma Investments's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- Two Sigma Investments fully exited Pfizer in Q1 2022, selling an estimated $271M.
- Two Sigma Investments's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- Two Sigma Investments opened 656 new positions and closed 2,305 in Q1 2022.
- Two Sigma Investments's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.